Advertisements


Gemphire Therapeutics" stock extends slide, plummets 39% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics stock tumbles 17% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Flex Pharma"s stock extends slide, plunges 67% premarket after ending phase 2 trial, cutting jobs

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 13th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Spark Therapeutics stock plummets 25% premarket on hemophilia trial"s patient safety concerns

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 7th, 2018

Spark Therapeutics stock plummets 28% premarket on hemophilia trial"s patient safety concerns

Spark Ther.....»»

Category: topSource: marketwatchAug 7th, 2018

Beyond Meat"s stock extends slide, falls 8.1% premarket

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 6th, 2019

Heron Therapeutics stock falls 31% premarket on resuming trade after halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 1st, 2019

Sangamo"s stock soars after upbeat trial data for hemophilia treatment

Shares of Sangamo Therapeutics Inc. soared 27% in premarket trade Tuesday, after the genomic .....»»

Category: topSource: marketwatchApr 2nd, 2019

Biogen"s stock plummets after phase 3 trial of Alzheimer"s treatment discontinued

Shares of Biogen Inc. plummeted 26% toward a near 3-year low in premarket trade Thursday, after the biotechnol.....»»

Category: topSource: marketwatchMar 21st, 2019

Boeing"s stock extends slide, falls 3.3% in premarket trade

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 12th, 2019

Boeing"s stock extends slide, on track to be a 60-point drag on the Dow

Shares of Boeing Co. sank 2.2% in premarket trade Tuesday, to extend the previous session's 5.3% drop in the wake of a second deadly crash of a 737 Max 8 aircraft made by th.....»»

Category: topSource: marketwatchMar 12th, 2019

Celldex"s stock plummets toward record low after failed drug study

Shares of Celldex Therapeutics Inc. plummeted 40% in premarket trade Monday toward a record low, after the drug.....»»

Category: topSource: marketwatchApr 16th, 2018

Vtv Therapeutics price plummets after disappointing trial results

High Point-based vTv Therapeutics LLC saw its stock price fall by more than 65 percent in after-market trading Monday after it disclosed disappointing results from the clinical trial of an experimental Alzheimer’s medication. The company ann.....»»

Category: topSource: bizjournalsApr 9th, 2018

Menlo Therapeutics" stock plunges over 50% after disappointing trial results

Shares of Menlo Therapeutics Inc. lost more than half their value in premarket trade Monday, after the biopharmaceutical company's skin condition treatment failed to meet its primary or key secondary efficacy endpoints. The phase 2 trial showed no stat.....»»

Category: topSource: marketwatchApr 9th, 2018

Tesla"s stock extends slide after GM"s self-driving unit gets $2.3 billion Softbank investment

Tesla Inc.'s stock fell 1.1% in premarket trade Thursday, extending their slide after General Motors Co. said SoftBank Vision Fund was planning a $2.25 billion investment in GM's self-driving unit. J.....»»

Category: topSource: marketwatchMay 31st, 2018

J.M. Smucker"s stock extends slide, plunges 8.4% premarket after Q4 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 7th, 2018

Snap stock extends slide after Needham cites "dramatic slowdown" of brand spending

Shares of Snap Inc. are down 1.9% in premarket trading Wednesday after Needham analyst Laura Martin lowered her c.....»»

Category: topSource: marketwatchJun 20th, 2018

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

Pain Therapeutics" stock plummets 70% after FDA advisory panel vote disappoints

Shares of Pain Therapeutics Inc. plummeted 70% toward a record low in premarket trade Wednesday, after a Food and Drug Administration advisory committee voted against the approval of Remoxy ER for the treatment of severe pain. .....»»

Category: topSource: marketwatchJun 27th, 2018

Boeing"s stock extends slide, falls 3.7% premarket after Q2 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJul 25th, 2018